Skip to main content
. 2017 May 18;22(20):30535. doi: 10.2807/1560-7917.ES.2017.22.20.30535

Figure 3.

Proportion of allergy-related adverse events following immunisation (AEFI) with trivalent influenza vaccines, by week from reporting commencement, Victoria, 2008–2015 (n = 1,010 total AEFI)

AEFI: adverse events following immunisation.

The y axis shows the proportion of allergy-related AEFI at the end of seasonal vaccination campaign.

Figure 3